208 related articles for article (PubMed ID: 28351298)
21. The presence of methylation of the p16INK4A gene and human papillomavirus in high-grade cervical squamous intraepithelial lesions.
Furtado YL; Almeida G; Lattario F; Silva KS; Maldonado P; Silveira FA; do Val IC; Fonseca R; Carvalho Mda G
Diagn Mol Pathol; 2010 Mar; 19(1):15-9. PubMed ID: 20186007
[TBL] [Abstract][Full Text] [Related]
22. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer.
Verlaat W; Snijders PJF; Novianti PW; Wilting SM; De Strooper LMA; Trooskens G; Vandersmissen J; Van Criekinge W; Wisman GBA; Meijer CJLM; Heideman DAM; Steenbergen RDM
Clin Cancer Res; 2017 Jul; 23(14):3813-3822. PubMed ID: 28119363
[No Abstract] [Full Text] [Related]
24. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma.
Pan Z; Li J; Pan X; Chen S; Wang Z; Li F; Qu S; Shao R
Tumori; 2009; 95(1):76-80. PubMed ID: 19366060
[TBL] [Abstract][Full Text] [Related]
25. Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings.
Wang KH; Liu HW; Lin SR; Ding DC; Chu TY
Cancer Sci; 2009 Nov; 100(11):2175-80. PubMed ID: 19709077
[TBL] [Abstract][Full Text] [Related]
26. CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.
Widschwendter A; Ivarsson L; Blassnig A; Müller HM; Fiegl H; Wiedemair A; Müller-Holzner E; Goebel G; Marth C; Widschwendter M
Int J Cancer; 2004 Mar; 109(2):163-6. PubMed ID: 14750164
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of the relationship between microRNA‑124a, -34b and -203 gene methylation and cervical oncogenesis.
Botezatu A; Goia-Rusanu CD; Iancu IV; Huica I; Plesa A; Socolov D; Ungureanu C; Anton G
Mol Med Rep; 2011; 4(1):121-8. PubMed ID: 21461574
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide host methylation profiling of anal and cervical carcinoma.
Siegel EM; Ajidahun A; Berglund A; Guerrero W; Eschrich S; Putney RM; Magliocco A; Riggs B; Winter K; Simko JP; Ajani JA; Guha C; Okawara GS; Abdalla I; Becker MJ; Pizzolato JF; Crane CH; Brown KD; Shibata D
PLoS One; 2021; 16(12):e0260857. PubMed ID: 34882728
[TBL] [Abstract][Full Text] [Related]
29. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma.
Zhang J; Martins CR; Fansler ZB; Roemer KL; Kincaid EA; Gustafson KS; Heitjan DF; Clark DP
Clin Cancer Res; 2005 Sep; 11(18):6544-9. PubMed ID: 16166431
[TBL] [Abstract][Full Text] [Related]
32. Aberrant promoter methylation of SH3GL2 gene in vulvar squamous cell carcinoma correlates with clinicopathological characteristics and HPV infection status.
Li B; He Y; Han X; Zhang S; Xu Y; Zhou Y; Song Z; Ouyang L
Int J Clin Exp Pathol; 2015; 8(11):15442-7. PubMed ID: 26823912
[TBL] [Abstract][Full Text] [Related]
33. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
34. CDH1 promoter methylation in patients with cervical carcinoma: a systematic meta-analysis with trial sequential analysis.
Liu G
Future Oncol; 2018 Jan; 14(1):51-63. PubMed ID: 29237293
[TBL] [Abstract][Full Text] [Related]
35. Promoter Methylation and Relative mRNA Expression of the p16 Gene in Cervical Cancer in North Indians.
Gupta A; Ahmad MK; Mahndi AA; Singh R; Pradeep Y
Asian Pac J Cancer Prev; 2016; 17(8):4149-54. PubMed ID: 27644676
[TBL] [Abstract][Full Text] [Related]
36. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
Henken FE; Wilting SM; Overmeer RM; van Rietschoten JG; Nygren AO; Errami A; Schouten JP; Meijer CJ; Snijders PJ; Steenbergen RD
Br J Cancer; 2007 Nov; 97(10):1457-64. PubMed ID: 17971771
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of candidate methylation markers to detect cervical neoplasia.
Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
[TBL] [Abstract][Full Text] [Related]
38. Aberrant DNA methylation in cervical carcinogenesis.
Yang HJ
Chin J Cancer; 2013 Jan; 32(1):42-8. PubMed ID: 22943599
[TBL] [Abstract][Full Text] [Related]
39. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
Kim HJ; Kim CY; Jin J; Bae MK; Kim YH; Ju W; Kim YH; Kim SC
Diagn Cytopathol; 2018 Jan; 46(1):15-21. PubMed ID: 29063719
[TBL] [Abstract][Full Text] [Related]
40. Quantitative DNA methylation analysis of candidate genes in cervical cancer.
Siegel EM; Riggs BM; Delmas AL; Koch A; Hakam A; Brown KD
PLoS One; 2015; 10(3):e0122495. PubMed ID: 25826459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
